The FDA has taken another step towards realizing their vision for encouraging pharmaceutical quality management practices. FDA’s Center for Drug Evaluation and Research (CDER) has developed […]
FDA Encourages Industry to Achieve Quality Management Maturity (QMM) Read More »
FDA’s Center for Drug Evaluation and Research (CDER) recently released its fifth annual report on the State of Pharmaceutical Quality. It reviews the state of
FDA Reports on the State of Pharmaceutical Quality Read More »
The Inflation Reduction Act (IRA) will drive a significant change in the pharmaceutical industry, empowering Medicare to negotiate the prices of high-cost single-source brand-name drugs
Price Negotiations: 10 Initiatives Pharma Must Consider To Mitigate Impacts Read More »
